Skip to main content


FibroBiologics endeavors to serve patients by harnessing the regenerative and immune modulation potential of fibroblasts using world-class science and a passionate research culture to cure individuals suffering from chronic disease.

Full Description

FibroBiologics is the leading biopharmaceutical company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases.


Our proprietary fibroblast platform serves as the foundation for developing biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.

Currently, FibroBiologics holds 150+ U.S. and International issued/pending patents across a variety of clinical pathways, including multiple sclerosis, cartilage repair, degenerative disc, cancer, wound healing, and extension of life programs.